Solana Co — Director's Dealing 2020

Apr 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2020-04-16

Reporting Person: Sackier Jonathan (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-16	Employee Stock Option (Right to Buy)	$0.32	A	50000	Acquired	2030-04-15	Class A Common Stock (50000)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of four (4) successive equal annual installments measured from April 16, 2020, subject to the Reporting Person's continued service through each applicable vesting date.